COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH COPD: TEMPORARY COMORBIDITY OR RISK FACTOR FOR DEATH?
At present, community-acquired pneumonia (CAP) is one of the leading places among common infectious diseases. Chronic constructive pulmonary disease is considered a risk factor for the development of community-acquired pneumonia, and numerous studies and studies on the study of community-acquired pneumonia have shown that COPD is mentioned as a concomitant pathology in 19–62 % of patients with CAP. As for statistics on the development of community-acquired pneumonia in patients with exacerbation of COPD, a small number of works on this problem are currently published. Most of these studies are devoted to clinical cases with severe exacerbation of COPD (with a picture of acute respiratory failure). According to international statistics, the mortality rate of patients with chronic obstructive pulmonary disease hospitalized with exacerbation to the hospital is 8 %, a year after the relapse – 23 %. If we talk about patients with acute respiratory failure amid exacerbation of COPD, then the death rate is 24 %, in patients older than 65 years – 30 %.
Uryasyev O.M., Panfilov Yu.A., Grinkova Y.N., Granatkin M.A., Pyko A.A. 2020. Community-acquired pneumonia in patients with COPD:temporary comorbidity or risk factor for death? Challenges in Modern Medicine, 43(1): 28–37 (in Russian). DOI
While nobody left any comments to this publication.
You can be first.
1. Avdeev S.N., Bajmakanova G.E., Zubairova P.A., Chuchalin A.G. 2006. Pnevmoniya kak prichina ostroj dyhatel'noj nedostatochnosti u bol'nyh HOBL [Pneumonia as a factor of acute respiratory failure in patients with COPD]. Pul'monologiya, 5: 115–119.
2. Bajmakova G.E., Zubairova P.A., Avdeev S.N., CHuchalin A.G. 2009. Osobennosti klinich-eskoj kartiny i techeniya vnebol'nichnoj pnevmonii u pacientov s hronicheskoj obstruktivnoj bolezn'yu legkih [Features of the clinical picture and course of community-acquired pneumonia in patients with chronic obstructive pulmonary disease]. Pul'monologiya, 2: 33–41.
3. Bilichenko T.N., Chuchalin A.G. 2018. Zabolevaemost' i smertnost' naseleniya Rossii ot os-tryh respiratornyh virusnyh infekcij, pnevmonii i vakcinoprofilaktika [Morbidity and mortality of the Russian population from acute respiratory viral infections, pneumonia and vaccine prophylaxis]. Tera-pevticheskij arhiv, 1: 22–26.
4. Vnebol'nichnaya pnevmoniya: klinicheskie rekomendacii [Community-acquired pneumonia: clinical guidelines]. 2018. 98 s.
5. Dvoreckij L.I. 2015. Vnebol'nichnaya pnevmoniya u bol'nyh hronicheskoj obstruktiynoj bolezn'yu legkih [Community-acquired pneumonia in patients with chronic obstructive pulmonary dis-ease]. Prakticheskaya pul'monologiya, 2: 17–24.
6. Efremova O.A., Kamyshnikova L.A., Sheljakina E.V., Shkiljova I.Ju., Hodosh Je.M., Efimenko E.V. Rol' hronicheskoj obstruktivnoj bolezni ljogkih v razvitii polimorbidnoj patologii [The role of chronic obstructive pulmonary disease in the development of polymorbidity pathology]. Nauchnyj rezul'tat. Medicina i farmacija. 2016. 2. (4): 13–18.
7. Ignat'ev V.A., Kiseleva E.A., Zarembo I.A., Cvetkova L.N., Kochergina T.A., Konev V.G., Pendyurin A.K. 2008. Pnevmoniya u pacientov pozhilogo i starcheskogo vozrasta. Some aspects of the development of pneumonia against the background of chronic obstructive pulmonary disease in the elder-ly]. Klinicheskaya gerontologiya, 6: 27–29.
8. Korreja L.L., Lebedev T.Yu., Efremova O.A., Proshchaev K.I., Litovchenko E.S. 2013. Problema polimorbidnosti pri sochetanii hronicheskoj obstruktivnoj bolezni legkih i nekotoryh ser-dechno-sosudistyh zabolevanij [The problem of polymorbidity of chronic obstructive pulmonary disease and some cardiovascular diseases]. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Medicina. Farmaciya. 4: 12–17.
9. Kuzubova N.A., Titova O.N., Volchkov V.A., Kozyrev A.G. 2014. Osobennosti vnebol'nich-noj pnevmonii u pacientov s hronicheskoj obstruktivnoj bolezn'yu legkih [Features of community-acquired pneumonia in patients with chronic obstructive pulmonary disease]. Trudnyj pacient, 3: 44–47.
10. Chernyaev A.L. 2005. Diagnosticheskie oshibki v pul'monologii [Diagnostic mistakes in pulmonology]. Pul'monologiya, 3: 5–12.
11. Chuchalin A.G. 2016. Rossijskoe respiratornoe obshchestvo. Federal'nye klinicheskie rek-omendacii po diagnostike i lecheniyu hronicheskoj obstruktivnoj bolezni legkih [Russian Respiratory So-ciety Federal clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary dis-ease]. M.: 68
12. Ewig S., Bauer T., Hasper E., Pizulli L., Kubini R., Luderitz B. 1995. Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. Eur. Respir. J., 8: 392–397.
13. Farr B.M., Sloman A.J., Fisch M.J. 1991. Predicting death in patients hospitalized for com-munity acquired pneumonia. Ann. Intern. Med., 115: 428–436.
14. GOLD. Global Initiative for chronic obstructive Lung Disease. Global strategy for the diag-nosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Update 2019 // www.goldcopd.com. 15. Groenewegen K.H., Schols A.M., Wouters E.F. 2003. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest., 124 (2): 459–467.
16. Huerta A., Crisafulli E., Mene´ndez R., Martínez R., Soler N., Guerrero M., Montull B., Torres A. 2013. Pneumonic and non-pneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest., 144: 1134–1142.
17. Lieberman D., Gelfer Y., Varshavsky R., Dvoskin B., Leinonen M., Friedman M.G. 2002. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest., 122(4): 1264–1270.
18. Lin S.H., Ji B.C., Shih Y.M., Chen C.H., Chan P.C., Chang Y.J., Lin Y.C., Lin C.H. 2013. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients. Int. J. Tu-berc. Lung Dis., 17: 1638.
19. Loke Y.K., Kwok C.S., Wong J.M., Sankaran P., Myint P.K. 2013. Chronic obstructive pul-monary disease and mortality from pneumonia: meta-analysis.Int. J. Clin. Pract., 67 (5): 477–487.
20. Mannino D.M., Davis K.J., Kiri V.A. 2009. Chronic obstructive pulmonary disease and hos-pitalizations for pneumonia in a US cohort. Respir. Med., 103: 224–229.
21. Merino-Sánchez, Alfageme-Michavila I., Lima-Álvarez J. 2005. Prognosis in Patients With Pneumonia and Chronic Obstructive Pulmonary Disease Arch Bronconeumol, 41: 607–611.
22. Müllerova H., Chigbo C., Hagan G.W., Woodhead M.A., Miravitlles M., Davis K.J., Wedzi-cha J.A. 2012. The natural history of communityacquired pneumonia in COPD patients: a population da-tabase analysis. Respir Med, 106: 1124–33.
23. Rello J., Rodriguez A., Torres A., Roig J., Sole-Violan J., Garnacho-Montero J., de la Tor-re M.V., Sirvent J.M., Bodi M. 2006. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur. Respir. J., 27: 1210.
24. Restrepo M.I., Mortensen E.M., Pugh J.A., Anzueto A. 2006. COPD is associated with in-creased mortality in patients with community-acquired pneumonia. Eur. Respir. J., 28: 346–351.
25. Seneff M.G., Wagner D.P., Wagner R.P., Zimmerman J.E., Knaus W.A. 1995. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA, 274: 1852–1857.
26. Sibila O. 2014. Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. Eur. Respir. J., 43(1): 36–42.